Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Aldeyra slides as lead drug flunks a primary endpoint in PhIIb
Aldeyra slides as lead drug flunks a primary endpoint in PhIIb
Aldeyra slides as lead drug flunks a primary endpoint in PhIIb
Submitted by
admin
on June 14, 2017 - 11:38am
Source:
Endpoints
News Tags:
Aldeyra Therapeutics
clinical trials
ADX-102
allergic conjunctivitis
Headline:
Aldeyra slides as lead drug flunks a primary endpoint in PhIIb
Do Not Allow Advertisers to Use My Personal information
